ArticleScientific reports2022

Beta-blocker/ACE inhibitor therapy differentially impacts the steady state signaling landscape of failing and non-failing hearts.

Andrea Sorrentino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.